LKT Labs

Biochemicals for Life Science Research

URB597

URB597

Product ID U682040
Cas No. 546141-08-6
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $57.20 In stock
25 mg $193.30 In stock
100 mg $565.10 In stock
Bulk Quote

Quicklinks

Description

URB597 is an inhibitor of fatty acid amide hydrolase (FAAH). FAAH inhibition leads to an increase of anandamide, a naturally occurring substrate for the cannabinoid receptors. Increase in anandamide and activation of the CB receptors decreases sensitivity to pain in rat models. Additionally, URB597 also decreases the amount of tyrosine hydrolase in neurons in a CB receptor/FAAH independent manner. URB597 also demonstrates an anti-neuroinflammatory effect in Sprague-Dawley rat models. URB597 shows analgesic effects in numerous pain models

Product Info

Cas No.

546141-08-6
Purity

≥98%
Formula

C20H22N2O3
Formula Wt.

338.41
Chemical Name

Cyclohexylcarbamic acid 3´-carbamoyl-biphenyl-3-yl ester
IUPAC Name

[3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate
Solubility

50mM in DMSO
Appearance

White powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

U682040 MSDS PDF
Info Sheet

U682040 Info Sheet PDF

References

Murphy N, Cowley TR, Blau CW et al. The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. J Neuroinflammation. 2012 Apr 26;9:79. PMID: 22537429.

Bosier B, Muccioli GG, and Lamber DM. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1 and FAAH-independent mechanisms. Br J Pharmacol. 2013 Jun;169(4):794-807. PMID: 22970888

Kwilasz AJ, Abdullah RA, Poklis JL et al. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats. Behav Pharmacol. 2014 Apr;25(2):119-29. PMID: 24583930

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P2994

    Physalaemin

    Amphibian tachykinin neuropeptide.

    ≥95%
  • P0010

    Pituitary Adenylate Cyclase-activating Polypeptide-related Peptide, human

    Peptide, involved in paracrine and autocrine ce...

    ≥95%
  • C4557

    Clofibrate

    Fibrate; PPARα agonist.

    ≥99%
  • H9620

    7-Hydroxyaristolochic Acid A

    Derivative of aristolochic acid found in Asarum...

    ≥95%
  • T1014

    7-TES-Paclitaxel

    Synthesis impurity

    ≥95%
  • S6233

    Spiramycin Hexanedioate

    Macrolide; protein synthesis inhibitor.

    ≥90%
  • S0044

    Salbutamol Free Base

    β2-adrenergic agonist.

    ≥98%
  • N3310

    Nicotinamide

    Amide form of vitamin B3 required for productio...

    ≥98%
  • P1755

    Pentoxifylline

    Xanthine derivative; adenosine A2 antagonist, P...

    ≥98%
  • T6931

    Triclosan

    Diarylether; bacterial ENR binder, fatty acid s...

    ≥98%
  • S584778

    Sotorasib

    KRAS inhibitor

    ≥99%
  • A4438

    Allatostatin I

    Neuropeptide found in insects; juvenile hormone...

    ≥95%
  • M5746

    Molsidomine

    NO donor; annexin A2 inhibitor.

    ≥98%
  • R1776

    Resveratrol

    Phenolic phytoalexin found in soy, grapes, and ...

    ≥99%
  • H9814

    25-Hydroxyvitamin D2

    Vitamin D2, ergocalciferol metabolite; VDR agon...

    ≥98%
  • G124082

    GDC-0941

    pan-PI3K inhibitor.

    ≥98%
  • A046189

    Abexinostat

    Primarily targets HDAC1

    ≥98%
  • G3357

    Ginkgolide C

    Diterpene lactone found in Ginkgo; GABA-A, α-1...

    ≥98%
  • L5769

    Lorglumide Sodium

    CCK antagonist.

    ≥98%
  • B8377

    5-tert-Butoxyquinazoline-2,4-diamine

    Diaminoquinazoline derivative.

    ≥98%